UGT2B17 Inhibitors

All categories
DBCAT005522Pharmacologic class

Inhibitors of UDP-Glucuronosyltransferase 2B17. A DrugBank category of 4 drugs. 4 of them are approved.

Part of
UDP Glucuronosyltransferases Inhibitors
Drugs

What you can answer from here — as of August 23, 2021

4DrugsEach linked to its full drug card
Listed above
26Drug targetsEvery drug–target pair in the class, with bond type
Sign in
10,313Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
19Routes of administrationHow the drugs in this class are given
Sign in
2ReferencesSupporting the category definition
Sign in

Which targets do UGT2B17 Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In